{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:35:04Z","timestamp":1783654504736,"version":"3.55.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate the relative risk of cervical neoplasms among copper intrauterine device (Cu IUD) and levonorgestrel-releasing intrauterine system (LNG-IUS) users.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We performed a retrospective cohort analysis of 10,674 patients who received IUDs at Columbia University Medical Center. Our data were transformed to a common data model and are part of the Observational Health Data Sciences and Informatics network. The cohort patients and outcomes were identified by a combination of procedure codes, condition codes, and medication exposures in billing and claims data. We adjusted for confounding with propensity score stratification and propensity score 1:1 matching.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Before propensity score adjustment, the Cu IUD cohort included 8,274 patients and the LNG-IUS cohort included 2,400 patients. The median age for both cohorts was 29 years at IUD placement. More than 95% of the LNG-IUS cohort used a device with 52 mg LNG. Before propensity score adjustment, we identified 114 cervical neoplasm outcomes. Seventy-seven (0.9%) cervical neoplasms were in the Cu IUD cohort and 37 (1.5%) were in the LNG-IUS cohort. The propensity score matching analysis identified 7,114 Cu IUD and 2,174 LNG-IUS users, with covariate balance achieved over 16,827 covariates. The diagnosis of high-grade cervical neoplasia was 0.7% in the Cu IUD cohort and 1.8% in the LNG-IUS cohort (2.4 [95% CI 1.5\u20134.0] cases\/1,000 person-years and 5.2 [95% CI 3.7\u20137.1] cases\/1,000 person-years, respectively). The relative risk of high-grade cervical neoplasms among Cu IUD users was 0.38 (95% CI 0.16\u20130.78, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.02) compared with LNG-IUS users. By inspection, the Kaplan-Meier curves for each cohort diverged over time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Copper IUD users have a lower risk of high-grade cervical neoplasms compared with LNG-IUS users. The relative risk of cervical neoplasms of LNG-IUS users compared with the general population is unknown.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000003656","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T18:11:15Z","timestamp":1578679875000},"page":"319-327","source":"Crossref","is-referenced-by-count":20,"title":["Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users"],"prefix":"10.1097","volume":"135","author":[{"given":"Matthew E.","family":"Spotnitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn L.","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/AOG.0000000000002307","article-title":"Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis","volume":"130","author":"Cortessis","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/AOG.0000000000000760","article-title":"Comparison of human papillomavirus infection and cervical cytology in women using copper-containing and levonorgestrel-containing intrauterine devices","volume":"125","author":"Lekovich","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.contraception.2007.01.015","article-title":"Endometrial effects of intrauterine levonorgestrel","volume":"75","author":"Guttinger","year":"2007","journal-title":"Contraception"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J"},{"issue":"Suppl","key":"R5-20230711","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/MLR.0b013e318259bff4","article-title":"Data model considerations for clinical effectiveness researchers","volume":"50","author":"Kahn","year":"2012","journal-title":"Med Care"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1073\/pnas.1510502113","article-title":"Characterizing treatment pathways at scale using the OHDSI network","volume":"113","author":"Hripcsak","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"R7-20230711","first-page":"574","article-title":"Observational health data sciences and Informatics (OHDSI): opportunities for observational researchers","volume":"216","author":"Hripcsak","year":"2015","journal-title":"Stud Health Technol Inform"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/amiajnl-2011-000376","article-title":"Validation of a common data model for active safety surveillance research","volume":"19","author":"Reich","year":"2012","journal-title":"J Am Med Inform Assoc"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/ajt.14892","article-title":"Expanding transplant outcomes research opportunities through the use of a common data model","volume":"18","author":"Cho","year":"2018","journal-title":"Am J Transplant"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/S0140-6736(19)32317-7","article-title":"Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis","volume":"394","author":"Suchard","year":"2019","journal-title":"Lancet"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/sim.5925","article-title":"Interpreting observational studies: why empirical calibration is needed to correct p-values","volume":"33","author":"Schuemie","year":"2014","journal-title":"Stat Med"},{"key":"R13-20230711","doi-asserted-by":"crossref","DOI":"10.1145\/2414416.2414791","article-title":"Massive parallelization of serial inference algorithms for a complex generalized linear model","volume":"23","author":"Suchard","year":"2013","journal-title":"ACM Trans Model Comput Simul"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/ije\/dyy120","article-title":"Evaluating large-scale propensity score performance through real-world and synthetic data experiments","volume":"47","author":"Ryan","year":"2018","journal-title":"Int J Epidemiol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bpobgyn.2014.05.004","article-title":"The intrauterine device and the intrauterine system","volume":"28","author":"Kinney","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"57.e1","DOI":"10.1016\/j.ajog.2017.03.005","article-title":"Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study","volume":"217","author":"Phillips","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2013.11.011","article-title":"Worldwide use of intrauterine contraception: a review","volume":"89","author":"Buhling","year":"2014","journal-title":"Contraception"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T21:36:30Z","timestamp":1689111390000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003656","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}